Exact Mass: 383.1328586

Exact Mass Matches: 383.1328586

Found 296 metabolites which its exact mass value is equals to given mass value 383.1328586, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Acetyllactosamine

N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

N-Acetyllactosamine, also known as galb1-4glcnacb or lacnac, belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through N-acyl group. N-Acetyllactosamine exists in all living organisms, ranging from bacteria to humans. Structural unit in higher oligosaccharides present in human milk N-Acetyllactosamine (LacNAc), a nitrogen-containing disaccharide, is an important component of various oligosaccharides such as glycoproteins and sialyl Lewis X. N-Acetyllactosamine can be used as the starting material for the synthesis of various oligosaccharides. N-Acetyllactosamine has prebiotic effects[1][2].

Fluazifop-butyl

Propanoic acid,2-[4-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]-, butyl ester

C19H20F3NO4 (383.1344356000001)

CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10066; ORIGINAL_PRECURSOR_SCAN_NO 10065 CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10009; ORIGINAL_PRECURSOR_SCAN_NO 10006 CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10055; ORIGINAL_PRECURSOR_SCAN_NO 10054 CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10034; ORIGINAL_PRECURSOR_SCAN_NO 10033 CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10019; ORIGINAL_PRECURSOR_SCAN_NO 10017 CONFIDENCE standard compound; INTERNAL_ID 1256; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10046; ORIGINAL_PRECURSOR_SCAN_NO 10044 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3093 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

tolfenpyrad

C21H22ClN3O2 (383.14004620000003)

CONFIDENCE standard compound; INTERNAL_ID 3873

Hydrastine

3-((5R)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5-yl))( 3S)-6,7-dimethoxy-3-hydroisobenzofuran-1-one

C21H21NO6 (383.13688060000004)

Hydrastine is a member of isoquinolines. It has a role as a metabolite. Hydrastine is a natural product found in Hydrastis canadensis, Fumaria indica, and other organisms with data available. See also: Goldenseal (part of). A natural product found in Hydrastis canadensis. Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.582 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.578 Hydrastine is a natural alkaloid which is present in Hydrastis canadensis and other plants of the ranunculaceae family.

Rheadine

Rhoeadine

C21H21NO6 (383.13688060000004)

Lacto-N-biose I

N-[(2S,3R,4R,5S,6R)-2,5-Dihydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]ethanimidate

C14H25NO11 (383.14275399999997)

Lacto-N-biose I is a common oligosaccharide found in human milk and in numerous other tissues. Oligosaccharides are important components of glycoproteins and glycolipids and also occur as free oligosaccharides in several body fluids.(PMID: 14993226; 11925506; 11432777; 9760191; 9592127; 8608564; 7591266; 7627975; 7766648; 1490103; 3146987; 6689405) [HMDB] Lacto-N-biose I is a common oligosaccharide found in human milk and in numerous other tissues. Oligosaccharides are important components of glycoproteins and glycolipids and also occur as free oligosaccharides in several body fluids.(PMID: 14993226; 11925506; 11432777; 9760191; 9592127; 8608564; 7591266; 7627975; 7766648; 1490103; 3146987; 6689405).

Corlumine

(+)-Adlumine

C21H21NO6 (383.13688060000004)

Phyllospadine

5,7-dihydroxy-2- (4-hydroxyphenyl) -6-methoxy-8- (1-methylpyrrolidin-2-yl) chromen-4-one

C21H21NO6 (383.13688060000004)

A trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7 and 4, a methoxy group at position 6 and a 1-methylpyrrolidin-2-yl group at position 8.

1-Adgmi

1-O-[2-(Acetylamino)-2-deoxy-alpha-D-glucopyranosyl]-D-myo-Inositol

C14H25NO11 (383.14275399999997)

β-D-Galp-(1→3)-D-GalpNAc

beta-D-Galp-(1->3)-D-GalpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of D-galactopyranose at the non-reducing end joined by a (1->3) glycosidic linkage to N-acetyl-beta-D-galactopyranose.

4-O-beta-D-Mannopyranosyl-N-acetyl-D-glucosamine

C14H25NO11 (383.14275399999997)

1S,9R-HYDRASTINE

(+)-beta-Hydrastine

C21H21NO6 (383.13688060000004)

13-Oxocryptopine

6,7-dimethoxy-12-methyl-16,18-dioxa-12-azatetracyclo[12.7.0.0⁴,⁹.0¹⁵,¹⁹]henicosa-1(14),4(9),5,7,15(19),20-hexaene-2,3-dione

C21H21NO6 (383.13688060000004)

13-Oxocryptopine is an alkaloid from Papaver somniferum (opium poppy). Alkaloid from Papaver somniferum (opium poppy).

Gravacridonediolacetate

2-Hydroxy-2-{5-hydroxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-2-yl}propyl acetic acid

C21H21NO6 (383.13688060000004)

Gravacridonediolacetate is found in herbs and spices. Gravacridonediolacetate is an alkaloid from Ruta graveolens (rue). Alkaloid from Ruta graveolens (rue). Gravacridonediolacetate is found in herbs and spices.

Poly-N-acetyllactosamine

N-[(2R,3R,4S,5R)-3,5,6-Trihydroxy-1-oxo-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexan-2-yl]ethanimidate

C14H25NO11 (383.14275399999997)

Poly-N-acetyllactosamine is a unique carbohydrate composed of N-acetyllactosamine repeats. In particular, poly-N-acetyllactosamine chains are synthesized by repeated alternating additions of N-acetylglucosamine and galactose, catalyzed by -1,3-N-acetylglucosaminyltransferases (poly-N-acetyllactosamine synthase) and -1,4-galactosyltransferases. What is depicted and described in this MetaboCard is a single subunit structure. Poly-N-acetyllactosamine structures occur in mammalian glycoproteins in both N- and O-linked glycans. They represent a backbone for additional modifications by fucosyltransferases, sialyltransferases and sulfotransferases. These glycans have been suggested to be involved in biospecific interactions with selectins and other glycan-binding proteins. Moreover, the poly-Nacetyllactosamine chains in N-glycans have been found to promote tumor progression and metastasis (PMID: 12570780) [HMDB] Poly-N-acetyllactosamine is a unique carbohydrate composed of N-acetyllactosamine repeats. In particular, poly-N-acetyllactosamine chains are synthesized by repeated alternating additions of N-acetylglucosamine and galactose, catalyzed by -1,3-N-acetylglucosaminyltransferases (poly-N-acetyllactosamine synthase) and -1,4-galactosyltransferases. What is depicted and described in this MetaboCard is a single subunit structure. Poly-N-acetyllactosamine structures occur in mammalian glycoproteins in both N- and O-linked glycans. They represent a backbone for additional modifications by fucosyltransferases, sialyltransferases and sulfotransferases. These glycans have been suggested to be involved in biospecific interactions with selectins and other glycan-binding proteins. Moreover, the poly-Nacetyllactosamine chains in N-glycans have been found to promote tumor progression and metastasis (PMID: 12570780).

beta-1,4-Mannosyl-N-acetylglucosamine

N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

beta-1,4-Mannosyl-N-acetylglucosamine, also known as 4-O-beta-D-Mannopyranosyl-N-acetyl-D-glucosamine or Man(β1-4)GlcNAc, is an intermediate in aminosugar metabolism. It is a substrate of lysosomal beta-mannosidase.

N-[(2R,3R,4R,5R)-3,5,6-Trihydroxy-1-oxo-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

C14H25NO11 (383.14275399999997)

Galbeta1-3GIcNAcbeta

N-[2,5-Dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]ethanimidate

C14H25NO11 (383.14275399999997)

Hydrastine

6,7-dimethoxy-3-{6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one

C21H21NO6 (383.13688060000004)

Thomsen-friedenreich antigen

N-(4,5,6-Trihydroxy-1-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexan-2-yl)ethanimidate

C14H25NO11 (383.14275399999997)

2-[(3,4-Dihydro-1-oxo-3-methyl-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester

C21H21NO6 (383.13688060000004)

yaequinolone B

C21H21NO6 (383.13688060000004)

leucosolenamine A

C17H17N7O4 (383.1341962)

N-[(3R)-(5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl]-L-phenylalanine|ochratoxin A

C21H21NO6 (383.13688060000004)

(+)-N-(methoxycarbonyl)-N-nordicentrin

C21H21NO6 (383.13688060000004)

1,8-dihydroxy-6-(hydroxymethyl)-3-methoxy-2-(piperidinium-2-yl) anthraquinone

C21H21NO6 (383.13688060000004)

1,2-(Methylenedioxy)-1,2-demethylcolchicine

C21H21NO6 (383.13688060000004)

leptocarpine

C21H21NO6 (383.13688060000004)

(+-)-12alpha-hydroxy-13-methyl-chelidonine|(+-)-12alpha-hydroxy-corynoline|(+/-)-12-hydroxycorynoline|12-Hydroxy-corynolin|5b,13-dimethyl-(5br,12bc)-5b,6,7,12b,13,14-hexahydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine-6t,7c-diol

(+-)-12alpha-hydroxy-13-methyl-chelidonine|(+-)-12alpha-hydroxy-corynoline|(+/-)-12-hydroxycorynoline|12-Hydroxy-corynolin|5b,13-dimethyl-(5br,12bc)-5b,6,7,12b,13,14-hexahydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine-6t,7c-diol

C21H21NO6 (383.13688060000004)

Coulteropine

C21H21NO6 (383.13688060000004)

O4-(2-acetylamino-2-deoxy-alpha-D-galactopyranosyl)-D-galactose|O4-(2-Acetylamino-2-desoxy-alpha-D-galactopyranosyl)-D-galactose

C14H25NO11 (383.14275399999997)

9-methoxy-6-methyl-6,9,7,8-tetrahydro-6H-spiro[[1,3]dioxolo[4,5-h]isochromene-7,5-[1,3]dioxolo[4,5-g]isoquinoline]|Papaver Rhoeas-Alkaloid A, Isorhoeadin|Rhoeadin

C21H21NO6 (383.13688060000004)

(S)-8,13-dimethoxy-5-methyl-4a,5,6,7-tetrahydro-4H-[1,3]dioxolo[4,5:4,5]benzo[1,2,3-de][1,3]dioxolo[4,5:3,4]benzo[1,2-g]quinoline|(S)-Ocotominarine|ocotominarine|Octominarin

C21H21NO6 (383.13688060000004)

Dihydropontevedrine

C21H21NO6 (383.13688060000004)

Asp Tyr Ser

C16H21N3O8 (383.1328586)

Tyr Ser Asp

C16H21N3O8 (383.1328586)

Ser Tyr Asp

C16H21N3O8 (383.1328586)

Tyr Asp Ser

C16H21N3O8 (383.1328586)

Yaequinolone B_120182

C21H21NO6 (383.13688060000004)

N-acetyllactosamine

N-Acetyl-D-lactosamine

C14H25NO11 (383.14275399999997)

A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-Acetyllactosamine (LacNAc), a nitrogen-containing disaccharide, is an important component of various oligosaccharides such as glycoproteins and sialyl Lewis X. N-Acetyllactosamine can be used as the starting material for the synthesis of various oligosaccharides. N-Acetyllactosamine has prebiotic effects[1][2].

HYDRASTINE (1R, 9S)

C21H21NO6 (383.13688060000004)

MMV688934

C21H22N3O2Cl (383.14004620000003)

MMV688846

C20H21NOClF3 (383.12636820000006)

(-)-B-Hydrastine

C21H21NO6 (383.13688060000004)

Annotation level-1

Rhoeadine

C21H21NO6 (383.13688060000004)

Annotation level-1

fluazifop-P-butyl

C19H20F3NO4 (383.1344356000001)

CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10058; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10080; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10114; ORIGINAL_PRECURSOR_SCAN_NO 10111 CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10122; ORIGINAL_PRECURSOR_SCAN_NO 10120 CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10095; ORIGINAL_PRECURSOR_SCAN_NO 10090 CONFIDENCE standard compound; INTERNAL_ID 215; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10142; ORIGINAL_PRECURSOR_SCAN_NO 10140 Fluazifop-P-butyl, a graminicide from arylophenoxypropionate group, is a acetyl-CoA carboxylase (ACCase) inhibitor[1].

HYDRASTINE (1R, 9S)_major

C21H21NO6 (383.13688060000004)

Asp Ser Tyr

C16H21N3O8 (383.1328586)

Ser Asp Tyr

C16H21N3O8 (383.1328586)

Not Available

Beta-1,4-mannose-N-acetylglucosamine

C14H25NO11 (383.14275399999997)

14-Oxocryptopine

6,7-dimethoxy-12-methyl-16,18-dioxa-12-azatetracyclo[12.7.0.0^{4,9}.0^{15,19}]henicosa-1(21),4(9),5,7,14,19-hexaene-2,3-dione

C21H21NO6 (383.13688060000004)

Gravacridonediolacetate

2-hydroxy-2-{5-hydroxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-2-yl}propyl acetate

C21H21NO6 (383.13688060000004)

Fmoc-Thr(Ac)-OH

C21H21NO6 (383.13688060000004)

2,2-[[3-methyl-4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]imino]bisethanol

C19H21N5O2S (383.14158860000003)

1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C20H22BNO4S (383.13625220000006)

4-hydroxy-1-methyl-3-[[4-(phenylazo)phenyl]azo]-2-quinolone

C22H17N5O2 (383.1382182)

AMG-208

7-Methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline

C22H17N5O2 (383.1382182)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Fmoc-D-2-aminoadipic acid

C21H21NO6 (383.13688060000004)

2-Acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-D-galactopyranose

C14H25NO11 (383.14275399999997)

3-O-(2-Acetamido-2-deoxy-b-D-glucopyranosyl)-D-mannopyranose

3-O-[2-Acetamido-2-deoxy-beta-D-glucopyranosyl]-D-mannopyranose

C14H25NO11 (383.14275399999997)

beta-D-Galp-(1->6)-D-GlcNAcp

2-Acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-D-glucopyranose

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of N-acetyl-D-glucosamine having a beta-D-galactosyl residue attached at the 6-position.

(-)-CorluMine

C21H21NO6 (383.13688060000004)

Gal-alpha1,3-GalNAc

2-ACETAMIDO-2-DEOXY-3-O-(ALPHA-D-GALACTOPYRANOSYL)-D-GALACTOSE

C14H25NO11 (383.14275399999997)

(+)-Carlumine

C21H21NO6 (383.13688060000004)

methyl 1-[(2-cyanobiphenyl-4-yl)methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-7-carboxylate

C23H17N3O3 (383.12698520000004)

Fmoc-Glu(Ome)-OH

C21H21NO6 (383.13688060000004)

Fmoc-D-Glu-OMe

C21H21NO6 (383.13688060000004)

3-O-[2-(Acetylamino)-2-deoxy-D-galactopyranosyl]-D-mannopyranose

C14H25NO11 (383.14275399999997)

1-(Phenylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C20H22BNO4S (383.13625220000006)

S-tubercidinylhomocysteine

C15H21N5O5S (383.12633360000007)

2-Acetamido-2-deoxy-3-O-hexopyranosylhexose

C14H25NO11 (383.14275399999997)

Lacto-N-biose II

C14H25NO11 (383.14275399999997)

2-[2-Chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)-3-methyloxolane-3,4-diol

C16H22ClN5O4 (383.1360242)

2'-MeCCPA is a potent and selective A1 adenosine receptors (A1AR) agonist. 2'-MeCCPA efficiently inhibits cAMP modulation in both direct pathway medium spiny neurons (dMSNs) and indirect pathway medium spiny neurons (iMSNs)[1][2]. 2'-MeCCPA is a potent and selective A1 adenosine receptors (A1AR) agonist. 2'-MeCCPA efficiently inhibits cAMP modulation in both direct pathway medium spiny neurons (dMSNs) and indirect pathway medium spiny neurons (iMSNs)[1][2].

2-Acetamido-2-deoxy-6-O-beta galactopyranosylgalactopyranose

C14H25NO11 (383.14275399999997)

2-[2,4-Dioxo-3-(2-phenylethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-1-yl]acetamide

C20H21N3O3S (383.13035560000003)

2-Acetamido-2-deoxy-4-O-(B-D-galactopyranosyl)-D-galactopyranose

C14H25NO11 (383.14275399999997)

N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

beta-D-GalNAc-(1->3)-D-Gal

C14H25NO11 (383.14275399999997)

A glycosylgalactose derivative consisting of D-galactose having a beta-D-N-acetylgalactosaminyl residue attached at the 3-position.

4-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-D-galactopyranose

C14H25NO11 (383.14275399999997)

N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

2-Acetamido-2-deoxy-4-O-beta-D-galactopyranosyl-D-mannopyranose

C14H25NO11 (383.14275399999997)

(S)-fluazifop-butyl

C19H20F3NO4 (383.1344356000001)

N-(1-(5-ethyl-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl)-2-(methylthio)benzamide

C19H21N5O2S (383.14158860000003)

2-(Acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-alpha-D-glucopyranose

C14H25NO11 (383.14275399999997)

Tcmdc-142628

C20H21ClF3NO (383.12636820000006)

8-beta-Methoxy-16-methyl-2,3:10,11-bis(methylenebis(oxy))rheadan

C21H21NO6 (383.13688060000004)

(+)-Hydrastine

(+)-beta-Hydrastine

C21H21NO6 (383.13688060000004)

N-Acetyl-D-lactosamine

C14H25NO11 (383.14275399999997)

N-Acetyllactosamine (LacNAc), a nitrogen-containing disaccharide, is an important component of various oligosaccharides such as glycoproteins and sialyl Lewis X. N-Acetyllactosamine can be used as the starting material for the synthesis of various oligosaccharides. N-Acetyllactosamine has prebiotic effects[1][2].

T-disaccharide

C14H25NO11 (383.14275399999997)

beta-D-Galp-(1->3)-beta-D-GalpNAc

C14H25NO11 (383.14275399999997)

A beta-D-Gal-(1->3)-D-GalNAc having beta-configuration at the reducing end anomeric centre.

(S)-7-(5-S-(3-amino-3-carboxypropyl)-5-thio-beta-D-ribofuranosyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine

C15H21N5O5S (383.12633360000007)

2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-beta-D-glucopyranose

C14H25NO11 (383.14275399999997)

(3S)-6,7-dimethoxy-3-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one

C21H21NO6 (383.13688060000004)

Adi saccharide

C14H25NO11 (383.14275399999997)

beta-D-GlcpNAc-(1->3)-beta-D-Galp

C14H25NO11 (383.14275399999997)

An amino disaccharide comprising N-acetyl-beta-D-glucosamine linked (1->3) to a beta-D-galactose residue.

N-Acetyl-Laktosamin

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-4-O-alpha-D-galactopyranosyl-D-galactopyranose

C14H25NO11 (383.14275399999997)

N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactose

C14H25NO11 (383.14275399999997)

Galalpha1-4GlcNAcbeta

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-3-O-alpha-D-galactopyranosyl-beta-D-galactopyranose

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-3-O-alpha-D-galactopyranosyl-alpha-D-galactopyranose

C14H25NO11 (383.14275399999997)

alpha-D-galactosyl-(1->4)-N-acetylglucosamine

C14H25NO11 (383.14275399999997)

N-acetyl-alpha-D-galactosaminyl-(1->4)-beta-D-galactose

C14H25NO11 (383.14275399999997)

beta-D-GalNAc-(1->3)-beta-D-Gal

C14H25NO11 (383.14275399999997)

beta-D-GalNAc-(1->3)-D-Gal with beta configuration at the anomeric carbon of the Gal residue.

Salmonella outer core terminal disaccharide

C14H25NO11 (383.14275399999997)

Beta-1,4-mannose-N-acetylglucosamine

C14H25NO11 (383.14275399999997)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

4-[[Oxo-[2-(2-pyridinyl)-4-quinolinyl]methyl]amino]benzoic acid methyl ester

C23H17N3O3 (383.12698520000004)

2-(4-Methylphenyl)sulfonyl-1-(4,6,7-trimethylquinazolin-2-yl)guanidine

C19H21N5O2S (383.14158860000003)

2-(2-Cyclohexyl-quinazolin-4-ylsulfanyl)-N-(4-methyl-furazan-3-yl)-acetamide

C19H21N5O2S (383.14158860000003)

N-(1,3-benzodioxol-5-yl)-6-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide

C23H17N3O3 (383.12698520000004)

1-(1,1-dioxo-1,2-benzothiazol-3-yl)-N-(2-methylphenyl)-4-piperidinecarboxamide

C20H21N3O3S (383.13035560000003)

2-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(3-ethylphenyl)-3-hydroxy-5-nitro-4-triazolimine

C18H17N5O5 (383.1229632)

N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannose

C14H25NO11 (383.14275399999997)

An amino disaccharide comprised of N-acetyl-beta-D-glucosamine linked (1->4) to D-mannose.

3-[5-(2,5-Dimethyl-1-phenyl-3-pyrrolyl)-1,3,4-oxadiazol-2-yl]-1-benzopyran-2-one

C23H17N3O3 (383.12698520000004)

GlcNAc(b1-3)Gal

C14H25NO11 (383.14275399999997)

N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2S,3S,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

Galbeta1,6GlcNAc

C14H25NO11 (383.14275399999997)

Man(b1-4)a-GlcNAc

C14H25NO11 (383.14275399999997)

GalNAc(a1-3)a-Gal

C14H25NO11 (383.14275399999997)

N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

GlcNAc(b1-6)a-Man

C14H25NO11 (383.14275399999997)

Gal(b1-6)a-GalNAc

C14H25NO11 (383.14275399999997)

Gal(b1-4)a-GalNAc

C14H25NO11 (383.14275399999997)

Gal(a1-3)b-GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-2)b-Man

C14H25NO11 (383.14275399999997)

GalNAc(b1-3)a-Gal

C14H25NO11 (383.14275399999997)

GlcNAc(a1-4)b-Gal

C14H25NO11 (383.14275399999997)

Glc(b1-4)b-GlcNAc

C14H25NO11 (383.14275399999997)

L-Gal(b1-3)b-GlcNAc

C14H25NO11 (383.14275399999997)

2-O-(2-Acetamido-2-deoxy-b-D-glucopyranosyl)-D-mannopyranose

C14H25NO11 (383.14275399999997)

N-acetyl-beta-D-galactosaminyl-(1->2)-beta-D-galactose

C14H25NO11 (383.14275399999997)

N-acetyl-alpha-D-galactosaminyl-(1->2)-beta-D-galactose

C14H25NO11 (383.14275399999997)

Ser-Asp-Tyr

C16H21N3O8 (383.1328586)

(+-)-Hydrastine

(+/-)-β-hydrastine

C21H21NO6 (383.13688060000004)

Galf(b1-4)GlcNAc

C14H25NO11 (383.14275399999997)

2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactofuranosyl-Alpha-D-Glucopyranose

C14H25NO11 (383.14275399999997)

N-acetyl-beta-D-glucosaminyl-(1->4)-D-galactose

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose

C14H25NO11 (383.14275399999997)

D-Galp-(1->4)-D-GlcpNAc

C14H25NO11 (383.14275399999997)

galactosyl (1-3)-N-acetyl galactosamine

C14H25NO11 (383.14275399999997)

Gal(b1-4)b-GalNAc

C14H25NO11 (383.14275399999997)

Gal(b1-4)a-ManNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-4)b-Gal

C14H25NO11 (383.14275399999997)

GalNAc(b1-4)b-Glc

C14H25NO11 (383.14275399999997)

GalNAc(b1-4)b-Gal

C14H25NO11 (383.14275399999997)

Glc(b1-3)a-GalNAc

C14H25NO11 (383.14275399999997)

2-[(5E)-2,4-dioxo-5-[(1,2,5-trimethylpyrrol-3-yl)methylidene]-1,3-thiazolidin-3-yl]-N-(4-methylphenyl)acetamide

C20H21N3O3S (383.13035560000003)

GlcNAc(b1-6)a-Gal

C14H25NO11 (383.14275399999997)

Asp-Tyr-Ser

C16H21N3O8 (383.1328586)

Tyr-Ser-Asp

C16H21N3O8 (383.1328586)

Asp-Ser-Tyr

C16H21N3O8 (383.1328586)

Ser-Tyr-Asp

C16H21N3O8 (383.1328586)

Tyr-Asp-Ser

C16H21N3O8 (383.1328586)

Gal(a1-3)GlcNAc

C14H25NO11 (383.14275399999997)

beta-D-GlcpNAc-(1->2)-beta-D-Glcp

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of an beta-D-glucose residue having an N-acetyl-beta-D-glucosaminyl residue attached at the 2-position.

D-galactosyl-(1->3)-N-acetyl-beta-D-galactosamine

C14H25NO11 (383.14275399999997)

Man(a1-4)GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-6)Man

C14H25NO11 (383.14275399999997)

GlcNAc(b1-4)Man

C14H25NO11 (383.14275399999997)

Man(a1-6)GlcNAc

C14H25NO11 (383.14275399999997)

Glc(b1-6)GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(a1-4)Man

C14H25NO11 (383.14275399999997)

Man(a1-3)GlcNAc

C14H25NO11 (383.14275399999997)

Glc(b1-3)GlcNAc

C14H25NO11 (383.14275399999997)

GalNAc(b1-4)Glc

C14H25NO11 (383.14275399999997)

GlcNAc(a1-3)Gal

C14H25NO11 (383.14275399999997)

GlcNAc(a1-3)Glc

C14H25NO11 (383.14275399999997)

Glc(a1-6)GlcNAc

C14H25NO11 (383.14275399999997)

GalNAc(a1-4)Gal

C14H25NO11 (383.14275399999997)

GalNAc(a1-2)Gal

C14H25NO11 (383.14275399999997)

GalNAc(b1-6)Gal

C14H25NO11 (383.14275399999997)

Gal(a1-6)GlcNAc

C14H25NO11 (383.14275399999997)

GalNAc(b1-2)Gal

C14H25NO11 (383.14275399999997)

Gal(a1-6)GalNAc

C14H25NO11 (383.14275399999997)

Glc(a1-4)GlcNAc

C14H25NO11 (383.14275399999997)

GalNAc(a1-6)Gal

C14H25NO11 (383.14275399999997)

GlcNAc(b1-2)Gal

C14H25NO11 (383.14275399999997)

GlcNAc(a1-1a)Glc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-1b)Gal

C14H25NO11 (383.14275399999997)

GlcNAc(b1-1a)Man

C14H25NO11 (383.14275399999997)

Gal(a1-6)b-GlcNAc

C14H25NO11 (383.14275399999997)

Glc(b1-3)a-GlcNAc

C14H25NO11 (383.14275399999997)

Man(a1-3)a-GlcNAc

C14H25NO11 (383.14275399999997)

Man(a1-4)a-GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-2)b-Gal

C14H25NO11 (383.14275399999997)

Gal(b1-6)a-GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-3)b-Man

C14H25NO11 (383.14275399999997)

GlcNAc(b1-4)b-Man

C14H25NO11 (383.14275399999997)

GlcNAc(a1-2)b-Glc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-3)a-Glc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-2)a-Gal

C14H25NO11 (383.14275399999997)

Gal(a1-3)a-GlcNAc

C14H25NO11 (383.14275399999997)

Glc(a1-3)a-GalNAc

C14H25NO11 (383.14275399999997)

Glc(a1-4)a-AllNAc

C14H25NO11 (383.14275399999997)

GlcNAc(b1-3)a-Man

C14H25NO11 (383.14275399999997)

GlcNAc(a1-3)b-Gal

C14H25NO11 (383.14275399999997)

GlcNAc(a1-3)a-Gal

C14H25NO11 (383.14275399999997)

Glc(b1-6)b-GlcNAc

C14H25NO11 (383.14275399999997)

GlcNAc(a1-4)b-Man

C14H25NO11 (383.14275399999997)

GalNAc(b1-4)a-Gal

C14H25NO11 (383.14275399999997)

Galf(a1-3)b-GlcNAc

C14H25NO11 (383.14275399999997)

L-Gal(b1-6)GalNAc

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-beta-D-manno-hexopyranose

C14H25NO11 (383.14275399999997)

D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

C14H25NO11 (383.14275399999997)

2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-alpha-D-manno-hexopyranose

C14H25NO11 (383.14275399999997)

D-manno-hexopyranosyl 2-acetamido-2-deoxy-D-gluco-hexopyranoside

C14H25NO11 (383.14275399999997)

D-gluco-hexopyranosyl 2-acetamido-2-deoxy-D-gluco-hexopyranoside

C14H25NO11 (383.14275399999997)

D-galacto-hexopyranosyl 2-acetamido-2-deoxy-D-gluco-hexopyranoside

C14H25NO11 (383.14275399999997)

(-)-alpha-Hydrastine

C21H21NO6 (383.13688060000004)

Galbeta1,3GlcNAc

6-chloro-2-(n-(2-diethylaminoethyl)-n-methylamino)-ortho-acetotoluidide dihydrochloride

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of beta-D-galactose linked via a (1->3)-glycosidic bond to N-acetyl-D-glucosamine.

(+)-Adlumine

C21H21NO6 (383.13688060000004)

1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside

C14H25NO11 (383.14275399999997)

beta-D-Gal-(1->3-)-alpha-D-GalNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide composed of D-galactose and N-acetyl-alpha-D-galactosaminyl residues in beta-(1->3) linkage.

FLUAZIFOP-BUTYL

Propanoic acid,2-[4-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]-, butyl ester

C19H20F3NO4 (383.1344356000001)

D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

beta-D-Manp-(1->4)-beta-D-GlcpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide comprising a beta-D-mannose residue linked (1->4) to an N-acetyl-beta-D-glucosamine residue at the reducing end.

N-[(2S,3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide

C14H25NO11 (383.14275399999997)

13-Oxocryptopine

C21H21NO6 (383.13688060000004)

alpha-D-GalNAc-(1->3)-D-Gal

C14H25NO11 (383.14275399999997)

A glycosylgalactose derivative consisting of D-galactose having an alpha-D-N-acetylgalactosaminyl residue attached at the 3-position.

alpha-D-Galp-(1->4)-D-GalpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of N-acetylgalactosamine having an alpha-D-galactosyl residue at the 4-position

alpha-D-GalpNAc-(1->3)-beta-D-Galp

C14H25NO11 (383.14275399999997)

An alpha-D-GalNAc-(1->3)-D-Gal having beta-configuration at the reducing end anomeric centre.

Galp-alpha-(1->4)-GlcpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide formed of alpha-D-galactopyranose in (1->4)-linkage with 2-acetamido-2-deoxyglucopyranose.

alpha-D-GalpNAc-(1->4)-beta-D-Galp

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of beta-D-galactose having an N-acetyl-alpha-D-galactosaminyl residue attached at the 4-position.

beta-D-GalpNAc-(1->2)-beta-D-Galp

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of beta-D-galactose having an N-acetyl-beta-D-galactosaminyl residue attached at the 2-position.

alpha-D-GalpNAc-(1->2)-beta-D-Galp

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of beta-D-galactose having an N-acetyl-alpha-D-galactosaminyl residue attached at the 2-position.

beta-D-GlcpNAc-(1->3)-D-Manp

C14H25NO11 (383.14275399999997)

An amino disaccharide comprised of N-acetyl-beta-D-glucosamine linked (1->3) to D-mannose.

beta-D-Galp-(1->3)-beta-D-GlcpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of beta-D-galactose linked via a (1->3)-glycosidic bond to N-acetyl-beta-D-glucosamine. beta-D-Galp-(1->3)-beta-D-GlcpNAc in which the configuration at the reducing-end anomeric centre is beta.

beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine

C14H25NO11 (383.14275399999997)

A disaccharide consisting of beta-D-galactose linked via a (1->4)-glycosidic bond to N-acetyl-D-glucosamine.

beta-D-GalNAc-(1->4)-D-Gal

C14H25NO11 (383.14275399999997)

A glycosylgalactose derivative consisting of D-galactose having a beta-D-N-acetylgalactosaminyl residue attached at the 4-position.

alpha-D-Galp-(1->3)-D-GalpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of N-acetylgalactosamine having an alpha-D-galactosyl residue at the 3-position

alpha-D-Galp-(1->3)-alpha-D-GalpNAc

C14H25NO11 (383.14275399999997)

An alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has alpha-configuration.

alpha-D-GlcpNAc-(1->2)-alpha-D-Glcp

C14H25NO11 (383.14275399999997)

An amino disaccharide consisting of an alpha-D-glucose residue having an N-acetyl-alpha-D-glucosaminyl residue attached at the 2-position.

alpha-D-Galp-(1->4)-beta-D-GlcpNAc

C14H25NO11 (383.14275399999997)

An amino disaccharide composed of D-galactose and 2-acetamido-2-deoxy-beta-D-glucopyranosyl residues in (alpha-1->4) linkage.

alpha-D-Galp-(1->3)-beta-D-GalpNAc

C14H25NO11 (383.14275399999997)

An alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has beta-configuration.

Adlumine

C21H21NO6 (383.13688060000004)

Fmoc-Glu-OMe

C21H21NO6 (383.13688060000004)

Fmoc-Glu-OMe, a glutamic acid derivative, shows antibacterial activity and gelation property in AgNO3 solution. Fmoc-Glu-OMe is a mouldable wound healing biomaterial[1].

(11s)-11-hydroxy-4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaen-12-one

C21H21NO6 (383.13688060000004)

24-methoxy-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15,17,22-hexaene

C21H21NO6 (383.13688060000004)

n-{5,19-dimethoxy-6-oxo-15,17-dioxatetracyclo[10.7.0.0²,⁸.0¹⁴,¹⁸]nonadeca-1(12),2,4,7,13,18-hexaen-9-yl}ethanimidic acid

C21H21NO6 (383.13688060000004)

n-{5,19-dimethoxy-6-oxo-15,17-dioxapentacyclo[10.7.0.0²,⁸.0³,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(8),4,12,14(18)-pentaen-9-yl}ethanimidic acid

C21H21NO6 (383.13688060000004)

5-amino-6-{[5-(2h-1,3-benzodioxol-5-ylmethyl)-2-iminoimidazol-4-yl]amino}-1,3-dimethylpyrimidine-2,4-dione

C17H17N7O4 (383.1341962)

11-hydroxy-4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaen-12-one

C21H21NO6 (383.13688060000004)

n-[(2r,3r,4r,5s,6r)-2-{[(3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C14H25NO11 (383.14275399999997)

10-(6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one

C21H21NO6 (383.13688060000004)

4-{[1-(hydroxymethyl)-8-methoxy-3-methyl-9-oxoxanthen-2-yl]oxy}-2-methylbut-2-enimidic acid

C21H21NO6 (383.13688060000004)

3-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2(10),3,8,14,16,21-hexaen-12-ol

C21H21NO6 (383.13688060000004)

12-hydroxycorynoline

C21H21NO6 (383.13688060000004)

{"Ingredient_id": "HBIN000875","Ingredient_name": "12-hydroxycorynoline","Alias": "NA","Ingredient_formula": "C21H21NO6","Ingredient_Smile": "CC12C(C(C3=CC4=C(C=C3C1N(CC5=C2C=CC6=C5OCO6)C)OCO4)O)O","Ingredient_weight": "383.4 g/mol","OB_score": "28.12224581","CAS_id": "104574-44-9","SymMap_id": "SMIT00731","TCMID_id": "9937","TCMSP_id": "MOL008631","TCM_ID_id": "NA","PubChem_id": "101806253","DrugBank_id": "NA"}

(1r,9r)-hydrastine

C21H21NO6 (383.13688060000004)

{"Ingredient_id": "HBIN003166","Ingredient_name": "(1r,9r)-hydrastine","Alias": "NA","Ingredient_formula": "C21H21NO6","Ingredient_Smile": "CN1CCC2=CC3=C(C=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OCO3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9702","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}